...
首页> 外文期刊>International heart journal >Time-domain heart rate variability in coronary artery disease patients affected by thyroid dysfunction
【24h】

Time-domain heart rate variability in coronary artery disease patients affected by thyroid dysfunction

机译:受甲状腺功能障碍影响的冠心病患者的时域心率变异性

获取原文
获取原文并翻译 | 示例

摘要

Subclinical hypothyroidism and hyperthyroidism have been recognized as clinical entities with negative effects on the cardiovascular system. Moreover, the effect of treated thyroid dysfunction on parameters associated with the cardiovascular control system has been poorly investigated. In the present study we analyzed time-domain heart rate variability in coronary artery disease (CAD) patients with known thyroid diseases. Twenty-four hour ECG monitoring was performed in 344 patients with coronary artery disease (174 with thyroid dysfunction and 170 without thyroid dysfunction used as a control group), using a 3-channel tape recorder. Time domain parameters of heart rate variability (HRV) were defi nitely lower both in patients with subclinical hypothyroidism and subclinical hyperthyroidism than in the control group, with statistically signifi cant differences in SDNN, RMSSD, TINN, and mean RR for both subgroups. Furthermore, patients on L-thyroxine treatment and restored euthyroidism had generally higher HRV values than patients with subclinical hypothyroidism, nevertheless SDNN, RMSSD, SDNN index, TINN, and mean RR were signifi cantly lower when compared to those of the control group. Signifi cant differences in HRV were also found between hyperthyroid patients under treatment and control group subjects with respect to RMSSD, TINN, and mean RR values. In conclusion, patients with cardiac disease and known thyroid disease, even when the disease is in the subclinical range or despite treatment, should be regarded as patients at additional risk conveyed by thyroid hormone disturbances.
机译:亚临床甲状腺功能减退症和甲状腺功能亢进症已被认为是对心血管系统具有负面影响的临床实体。此外,对甲状腺功能障碍的治疗对与心血管控制系统有关的参数的影响研究很少。在本研究中,我们分析了患有已知甲状腺疾病的冠心病(CAD)患者的时域心率变异性。使用3通道磁带录音机对344例冠心病(174例甲状腺功能异常和170例无甲状腺功能异常的患者)进行了24小时ECG监测。亚临床甲状腺功能减退症和亚临床甲状腺功能亢进症患者的心率变异性(HRV)时域参数均明显低于对照组,SDNN,RMSSD,TINN和平均RR在两个亚组中均具有统计学意义。此外,接受L-甲状腺素治疗并恢复了甲状腺功能正常的患者通常比亚临床甲状腺功能减退的患者具有更高的HRV值,但与对照组相比,SDNN,RMSSD,SDNN指数,TINN和平均RR显着降低。在接受治疗的甲状腺功能亢进患者与对照组之间,在RMSSD,TINN和平均RR值方面,HRV也存在显着差异。总之,患有心脏病和已知甲状腺疾病的患者,即使该疾病处于亚临床范围内或经过治疗也应被视为因甲状腺激素紊乱而带来额外风险的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号